Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
https://t.co/gm76Pzw0KT
In memoriam Nicola Bidoli
More from rubic3n
2017
Pushing the
CEPI Dialogue
Excellent presentation to see, how they, including Bancel, had layed out the narrative.
Quess, what they had specifically included in their list of targeted viruses?
https://t.co/J5FDe6W986
Fondation Merieux 2017
CEPI
Almost basking about their list being more inclusive, more emergent viruses based.
https://t.co/J5FDe6W986
Fondation Merieux 2017
Narrative: "Look, what ZIKA has done to your populace. Nasty ZIKA."
How much of that ZIKA damage was actually related to a virus? Was there a computer guy, who had invested in mosquitos as a vector?
https://t.co/J5FDe6W986
Fondation Merieux 2017
What is the advanges of a programme like CEPI.
And for who?
Let me translate: They want a coordinated vaccine production, with only one strong production pipeline, and solidly regulated pathsways.
Provide the incentives for big pharma.
They've made it.
Vision - look at nasty ZIKA, you surely do not want that
Mission - get the pipeline going of (only) the big ones
Scope - the anti-cancer platforms with their DNA, mRNA basis fit perfectly. They so far do not sell very well, but they could be recycled.
Correct me, if I am wrong.
An 80% market for mRNA. Yet, the vector is the bottleneck causing the limitation.
Viral V is almost a 'use once only' bcs of antibody formation.
LNP sole way to push.
READ THE INTRODUCTION... https://t.co/1k4qZeutit
— Not Your Mom (@Notyour28981739) December 24, 2021
mRNA Therapy - with a gargantuan market - in dire need for a vector.
Viral vectors as a dead ally until 2015.
mRNA Therapy meets enormous resentments.
Luckily, billions of people have now got first hand experience. Obviously, AZ was not that useful in the general drift.
LNP instead of a vector
PFIZER BioNtech
ALC-0315
ALC-0159, DSPC
"This product is for research use only and not for human use."
https://t.co/tNsG5wxVCT
'EMA Zulassung ohne
https://t.co/rSOxRFTZwHhttps://t.co/gi40e7mUqIhttps://t.co/3yAElKnXgshttps://t.co/QXYZbFxHRqhttps://t.co/Nb0q026Zvj
— Lexa W. \U0001f1e9\U0001f1ea (@rebew_lexa) December 22, 2021
Official statement by Echelon
Paraphrased - "we do produce it, but only for use in labs.
Pfizer get theirs from other companies. With them it is safe in humans."
No study data presented
A reference to GMP as 'safe in humans'
ALC-0315
ALC-0159, DSPC
PFIZER LNP
This paper claims "It is just like another fatty compound. You eat salad oil and chips as well"
https://t.co/uncdUpkFnI
No, it is not.
Matrix M coating for cancer therapeutics
Following in the orchestrated wave if 'Emerging infectious diseases'.
A good cloak to hide a nasty machinery beneath.
2022
https://t.co/gm76Pzw0KT
further articles in following tweet
2017 Biomerieux
https://t.co/hrCU2xVi3U
2016
https://t.co/ZpyQ4WeUWZ
2016
https://t.co/ua10Y0fu0Z
2015 mice
Nachfolgend
- zum Bau des Labors in Wuhan durch BioMerieux -> Bancel jetzt Moderna
- Werbebroschüre BioMerieux (CEPI GAVI Einbindung)
- Moderna ominöser geheimer weiterer Impfstoff
1
Bau des Labors in Wuhan BioMerieux Beteiligung
2004
CCP
— rubic3n (@rubic3n) February 19, 2021
US
France
all in.
Gates Biontech, Biomerieux Moderna, Gilead Trump
All in.
Who is more?@franciscodeasis https://t.co/ADowRaYHsL
Bancel BioMerieux
However, through the Bancel (WEF), James Le Duc, Biomerieux gateway France still stayed pretty well in the game - however, sophisticatedly covered. Quite a camouflage masterpiece.
— rubic3n (@rubic3n) August 29, 2021
This is where 100Mio EU funding went?https://t.co/hFvdBS62rYhttps://t.co/jkJgyBdiYk pic.twitter.com/rulfKhKIWw
Mehr zum Bau des Labors durch BioMerieus in Wuhan (Stephane Bancel ex BioMerieux jetzt
biomerieux has the lab in lyon and they also made the lab in wuhan. https://t.co/dmgTLZ1kEK
— Bianca, fight the abolition of human rights (@Bianca50406170) November 16, 2021
Bancel BioMerieux Wuhan
I\u2019m wondering if/when this will catch on... https://t.co/PoBxz4JyiW pic.twitter.com/1rZFot4uxr
— Jesse \u201cEpstein+WEF+\U0001f1fa\U0001f1f3=Malthusianism\U0001f489\u201d Matchey (@JesseMatchey) January 9, 2022
You May Also Like
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the
chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project
starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".
P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!
https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?
If everyone was holding bitcoin on the old x86 in their parents basement, we would be finding a price bottom. The problem is the risk is all pooled at a few brokerages and a network of rotten exchanges with counter party risk that makes AIG circa 2008 look like a good credit.
— Greg Wester (@gwestr) November 25, 2018
The benign product is sovereign programmable money, which is historically a niche interest of folks with a relatively clustered set of beliefs about the state, the literary merit of Snow Crash, and the utility of gold to the modern economy.
This product has narrow appeal and, accordingly, is worth about as much as everything else on a 486 sitting in someone's basement is worth.
The other product is investment scams, which have approximately the best product market fit of anything produced by humans. In no age, in no country, in no city, at no level of sophistication do people consistently say "Actually I would prefer not to get money for nothing."
This product needs the exchanges like they need oxygen, because the value of it is directly tied to having payment rails to move real currency into the ecosystem and some jurisdictional and regulatory legerdemain to stay one step ahead of the banhammer.